title: C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population.
abstract: OBJECTIVE
  The inflammatory marker C-reactive protein (CRP) has been strongly correlated with the risk of cardiovascular disease. Some single-nucleotide polymorphisms (SNPs) have been reported to be associated with serum CRP levels. In this study, we assessed the genetic association between SNPs within the CRP gene and ischemic and hemorrhagic stroke in the Han Chinese population.
  
  
  METHODS
  This study comprises 564 ischemic stroke patients, 220 hemorrhagic stroke patients and 564 controls from the ethnic Han Chinese population in Wuhan. Four CRP SNPs, -757A>G (rs3093059), -717A>G (rs2794521), -286C>T>A (rs3091244) and +2147C>T (rs1205), were genotyped from patients using TaqMan assays.
  
  
  RESULTS
  The A allele frequency for the -717A>G polymorphism was significant higher in controls than in ischemic stroke patients (P=0.037), after adjustment for traditional risk factors (odds ratio 0.28; 95% CI 0.12-0.65; P=0.003), suggesting a protective effect for this allele against ischemic stroke. Haplotype analysis showed that the H3 (G-C-C) haplotype conferred a significantly increased risk of ischemic stroke (odds ratio 1.052, 95% CI 1.001-1.106: P=0.047). Neither CRP genotypes nor haplotypes showed an association with hemorrhagic stroke. However, the frequency for haplotype H5 (A-T-C) was significantly higher in ischemic stroke than hemorrhagic stroke patients (P=0.0003).
  
  
  CONCLUSIONS
  These data suggest that the CRP gene -717A allele confers a protective effect against ischemic stroke. Furthermore, the H3 haplotype (G-C-C) is an independent risk marker for ischemic stroke, whereas the H5 haplotype (A-T-C) can be used as a prognostic marker of hemorrhagic stroke.
authors.affiliation: The Institute of Hypertension and Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
authors.forename: Qi
authors.initials: Q
authors.lastname: Wang
authors.forename: Hu
authors.initials: H
authors.lastname: Ding
authors.forename: Jia-rong
authors.initials: JR
authors.lastname: Tang
authors.forename: Lan
authors.initials: L
authors.lastname: Zhang
authors.forename: Yu-jun
authors.initials: YJ
authors.lastname: Xu
authors.forename: Jiang-tao
authors.initials: JT
authors.lastname: Yan
authors.forename: Wei
authors.initials: W
authors.lastname: Wang
authors.forename: Ru-tai
authors.initials: RT
authors.lastname: Hui
authors.forename: Cong-yi
authors.initials: CY
authors.lastname: Wang
authors.forename: Dao-wen
authors.initials: DW
authors.lastname: Wang
mesh_terms: D000483:Alleles; D015415:Biomarkers; D002545:Brain Ischemia / Q000208:ethnology / Q000235:genetics*; D002097:C-Reactive Protein / Q000235:genetics*; D002543:Cerebral Hemorrhage / Q000208:ethnology / Q000235:genetics*; D002681:China; D005260:Female; D020022:Genetic Predisposition to Disease / Q000208:ethnology; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D020521:Stroke / Q000208:ethnology / Q000235:genetics*
chemical_list: D015415:Biomarkers; D002097:C-Reactive Protein